tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NTLA is currently covered by 23 analysts with an average price target of $43.24. This is a potential upside of $33.3 (335.01%) from yesterday's end of day stock price of $9.94.
Intellia Therapeutics's activity chart (see below) currently has 163 price targets and 178 ratings on display. The stock rating distribution of NTLA is 28.36% HOLD, 70.15% BUY and 1.49% SELL.
Analysts average stock forecasts to be materialized ratio is 40.01% with an average time for these price targets to be met of 110.47 days.
Highest price target for NTLA is $91, Lowest price target is $12, average price target is $43.24.
Most recent stock forecast was given by SALVEEN RICHTER from GOLDMAN SACHS on 14-Jan-2025.
Currently out of the existing stock ratings of NTLA, 19 are a HOLD (28.36%), 47 are a BUY (70.15%), 1 are a SELL (1.49%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12
$2.5 (26.32%)
$20
7 days ago
(14-Jan-2025)
4/7 (57.14%)
$2.26 (23.20%)
20
Buy
$40
$30.5 (321.05%)
$60
8 days ago
(13-Jan-2025)
2/11 (18.18%)
$30.13 (305.27%)
53
Buy
$60
$50.5 (531.58%)
$70
11 days ago
(10-Jan-2025)
1/4 (25%)
$49.8 (488.24%)
3
Buy
$50
$40.5 (426.32%)
$70
11 days ago
(10-Jan-2025)
2/7 (28.57%)
$39.8 (390.20%)
11
Hold
$14
$4.5 (47.37%)
$29
2 months 3 days ago
(18-Nov-2024)
8/10 (80%)
$-0.02 (-0.14%)
351
What is NTLA (Intellia Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NTLA (Intellia Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NTLA (Intellia Therapeutics)?
Which analyst is the currently most bullish on NTLA (Intellia Therapeutics)?
Which analyst is the currently most reserved on NTLA (Intellia Therapeutics)?
